Research Spotlight: Shining light on nuclear-targeted therapy using gold nanostar constructs

Duncan Hieu M Dam, Kayla S B Culver, Patrick N. Sisco, Teri W Odom

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Nuclear-targeted therapy has received increasing attention as a potential strategy to improve the therapeutic efficacy of treating cancer. The main challenges include targeting, drug-delivery efficiency and release of anticancer agents to the cancer cell nucleus. Nanoparticles as nanocarriers have started to address some of these issues. However, a lack of understanding in how nanoconstructs interact with the nucleus has precluded detailed studies. In this article, we highlight a nanoconstruct composed of gold (Au) nanostars loaded with nucleolin-specific aptamers. This nanoconstruct induced major changes in the nuclear phenotype through nuclear envelope (NE) invaginations. Femtosecond, light-triggered release of the aptamers from the surface of the Au nanostars further increased the number of NE deformations. Cancer cells with more NE folding showed increased apoptosis as well as decreased cell viability. The author's of this article have revealed that correlation between drug-induced changes in nuclear phenotypes and increased therapeutic efficacy can provide new insight into nuclear-targeted cancer therapy.

Original languageEnglish
Pages (from-to)1263-1267
Number of pages5
JournalTherapeutic Delivery
Volume3
Issue number11
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Gold
Nuclear Envelope
Research
Neoplasms
Phenotype
Therapeutics
Drug Delivery Systems
Cell Nucleus
Antineoplastic Agents
Nanoparticles
Cell Survival
Apoptosis
Light
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Research Spotlight : Shining light on nuclear-targeted therapy using gold nanostar constructs. / Dam, Duncan Hieu M; Culver, Kayla S B; Sisco, Patrick N.; Odom, Teri W.

In: Therapeutic Delivery, Vol. 3, No. 11, 11.2012, p. 1263-1267.

Research output: Contribution to journalArticle

Dam, Duncan Hieu M ; Culver, Kayla S B ; Sisco, Patrick N. ; Odom, Teri W. / Research Spotlight : Shining light on nuclear-targeted therapy using gold nanostar constructs. In: Therapeutic Delivery. 2012 ; Vol. 3, No. 11. pp. 1263-1267.
@article{614085575497450081ae0d10e91c2eb6,
title = "Research Spotlight: Shining light on nuclear-targeted therapy using gold nanostar constructs",
abstract = "Nuclear-targeted therapy has received increasing attention as a potential strategy to improve the therapeutic efficacy of treating cancer. The main challenges include targeting, drug-delivery efficiency and release of anticancer agents to the cancer cell nucleus. Nanoparticles as nanocarriers have started to address some of these issues. However, a lack of understanding in how nanoconstructs interact with the nucleus has precluded detailed studies. In this article, we highlight a nanoconstruct composed of gold (Au) nanostars loaded with nucleolin-specific aptamers. This nanoconstruct induced major changes in the nuclear phenotype through nuclear envelope (NE) invaginations. Femtosecond, light-triggered release of the aptamers from the surface of the Au nanostars further increased the number of NE deformations. Cancer cells with more NE folding showed increased apoptosis as well as decreased cell viability. The author's of this article have revealed that correlation between drug-induced changes in nuclear phenotypes and increased therapeutic efficacy can provide new insight into nuclear-targeted cancer therapy.",
author = "Dam, {Duncan Hieu M} and Culver, {Kayla S B} and Sisco, {Patrick N.} and Odom, {Teri W}",
year = "2012",
month = "11",
doi = "10.4155/tde.12.107",
language = "English",
volume = "3",
pages = "1263--1267",
journal = "Therapeutic Delivery",
issn = "2041-5990",
publisher = "Future Science",
number = "11",

}

TY - JOUR

T1 - Research Spotlight

T2 - Shining light on nuclear-targeted therapy using gold nanostar constructs

AU - Dam, Duncan Hieu M

AU - Culver, Kayla S B

AU - Sisco, Patrick N.

AU - Odom, Teri W

PY - 2012/11

Y1 - 2012/11

N2 - Nuclear-targeted therapy has received increasing attention as a potential strategy to improve the therapeutic efficacy of treating cancer. The main challenges include targeting, drug-delivery efficiency and release of anticancer agents to the cancer cell nucleus. Nanoparticles as nanocarriers have started to address some of these issues. However, a lack of understanding in how nanoconstructs interact with the nucleus has precluded detailed studies. In this article, we highlight a nanoconstruct composed of gold (Au) nanostars loaded with nucleolin-specific aptamers. This nanoconstruct induced major changes in the nuclear phenotype through nuclear envelope (NE) invaginations. Femtosecond, light-triggered release of the aptamers from the surface of the Au nanostars further increased the number of NE deformations. Cancer cells with more NE folding showed increased apoptosis as well as decreased cell viability. The author's of this article have revealed that correlation between drug-induced changes in nuclear phenotypes and increased therapeutic efficacy can provide new insight into nuclear-targeted cancer therapy.

AB - Nuclear-targeted therapy has received increasing attention as a potential strategy to improve the therapeutic efficacy of treating cancer. The main challenges include targeting, drug-delivery efficiency and release of anticancer agents to the cancer cell nucleus. Nanoparticles as nanocarriers have started to address some of these issues. However, a lack of understanding in how nanoconstructs interact with the nucleus has precluded detailed studies. In this article, we highlight a nanoconstruct composed of gold (Au) nanostars loaded with nucleolin-specific aptamers. This nanoconstruct induced major changes in the nuclear phenotype through nuclear envelope (NE) invaginations. Femtosecond, light-triggered release of the aptamers from the surface of the Au nanostars further increased the number of NE deformations. Cancer cells with more NE folding showed increased apoptosis as well as decreased cell viability. The author's of this article have revealed that correlation between drug-induced changes in nuclear phenotypes and increased therapeutic efficacy can provide new insight into nuclear-targeted cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=84870173511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870173511&partnerID=8YFLogxK

U2 - 10.4155/tde.12.107

DO - 10.4155/tde.12.107

M3 - Article

C2 - 23259247

AN - SCOPUS:84870173511

VL - 3

SP - 1263

EP - 1267

JO - Therapeutic Delivery

JF - Therapeutic Delivery

SN - 2041-5990

IS - 11

ER -